Fundraising FoxCryOSA
Arden Hills, US · Founded 2018 · Delaware corporation · 2 known investors
Find your way into CryOSA
Sign up to see every warm intro you have to CryOSA
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CryOSA team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cryosa develops an incisionless medical treatment that uses controlled cooling to reduce tissue and open airways. The company serves patients requiring airway management procedures.
Founders & leadership
LS
Laura StoltenbergExecutiveLaura Stoltenberg is an executive with experience in medical devices, life sciences, and health care IT, having held general management, business development, and P&L leadership roles across commercial and strategic planning functions. She has worked with FDA, payers, and health care providers and led teams that developed products demonstrating clinical and economic outcomes.
Board
DB
DF
Doug FrenchBoard director
JE
James EadieBoard director
DG
Donald GonzalesFounder and Chief Medical Officer
Investors · 2
Brightstone Venture Capitallisted by Brightstone Venture CapitalMinneapolis · $250K – $10M
How we know: Brightstone Venture Capital's portfolio page · Not right? Tell us
Solas BioVentureslisted by Solas BioVenturesChattanooga
How we know: Solas BioVentures's portfolio page · a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$7M disclosed across 2 rounds · 2018–2025
▶$6MraisedAug 2025 · 20 investors · BiotechnologyRule 506(b)
▶$6MraisedAug 2025 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Doug FrenchDirector
- James EadieDirector
- Donald GonzalesDirector
- David BelitzDirector
- Laura StoltenbergExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $6M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$997.3KraisedMay 2018 · 6 investors · Other Health CareRule 506(b)
▶$997.3KraisedMay 2018 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Donald GonzalesExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $997.3K
- Minimum investment
- $1
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does CryOSA do?
- Cryosa develops an incisionless medical treatment that uses controlled cooling to reduce tissue and open airways. The company serves patients requiring airway management procedures.
- Who are CryOSA's investors?
- CryOSA's investors include Brightstone Venture Capital, Solas BioVentures.
- How much funding has CryOSA raised?
- CryOSA has disclosed $7M raised across 2 rounds.
- Where is CryOSA headquartered?
- CryOSA is headquartered in Arden Hills, US.